Infection is the complication most likely to end with the implant being removed. It usually appears weeks after surgery, when the patient is at home. It can also delay cancer treatment. This article explains who is at risk, what helps to prevent it, and how often an infected reconstruction can be saved.
In short
- Most infections appear in the first month.
- Higher body weight, diabetes and wound problems raise the risk.
- One day of antibiotics worked as well as a longer course in a randomised trial.
- Protecting the wound is one of the better-supported ways to prevent infection.
- Many infected reconstructions can be saved without months of waiting.
How often, and when
Studies report very different rates, because they count different things. Some count any redness treated with tablets. Others count only infections that needed surgery. In 292 implant reconstructions in one hospital, 19% had an infection of some kind.1 In 326 prepectoral reconstructions in Germany, 4.0% had an infection that needed an operation.2
Patients should know what to report: new redness, swelling, warmth, fever, or a change in the fluid from the wound.
Who is at higher risk
The link is the wound. Steps that protect the skin also protect the implant. See flap necrosis risk assessment and seroma after mastectomy.
What helps to prevent it
Antibiotics for one day. Many surgeons still give antibiotics for a week or more. The studies do not support this.3 4 5
In the randomised trial, 4.8% of patients lost their implant in the one-day group and 14.0% in the longer group.3
Protecting the wound. A special suction dressing over the closed wound (negative-pressure therapy) was linked to less skin loss, 5.6% against 14.3%, and fewer wound problems overall, 10.6% against 21.1%, in a pooled analysis of 1,200 breasts.8
Washing the pocket. Rinsing the space for the implant with an antibiotic or antiseptic solution is common and reasonable. A review found only nine studies and no agreed best solution.6
Antibiotics placed in the pocket. Beads or plates that release antibiotics look promising in six studies, but the evidence is not yet strong.7
A shorter, simpler operation. Long operating times and drains were linked to infection.1 Handling the implant as little as possible follows the same idea. Wrapping the implant in a pre-shaped matrix pocket on a side table, before it goes in, fits that idea too.
Can an infected reconstruction be saved?
Often, yes.
In the 292-patient study, 61.5% of infected reconstructions were saved with surgery.1 In a prepectoral series, 8 of 11 infected implants were saved with antibiotics alone.5
When surgery is needed, the aim today is to keep the pocket and put a new implant in soon. In eight infected prepectoral reconstructions, surgeons removed the expander, washed the pocket with a pulsed antibiotic rinse, and placed the final implant in the same operation. All eight infections cleared.9 A suction dressing that also rinses the pocket has been studied more: about 92% of pockets were saved in one review of 115 patients, and 86.1% in a pooled analysis of nine studies.10 11 These figures come from small case series.
Saving the implant is less likely when the patient is very unwell, the implant is exposed, or the skin is already damaged by poor blood supply or radiotherapy. Then it is safer to remove the implant and rebuild later.
What it means in practice
Choose and prepare the patient: weight, diabetes and skin blood supply matter most. Give antibiotics for 24 hours. Protect the wound in higher-risk patients. Keep the operation short and handle the implant little. Teach patients the warning signs. And if infection occurs, take a sample, start antibiotics early, and consider saving the pocket before removing everything.
References
- Boustany AN, Elmaraghi S, Agochukwu N, et al. A breast prosthesis infection update: two-year incidence, risk factors and management at single institution. Indian J Plast Surg. 2018;51(1):7-14. doi:10.4103/ijps.IJPS_215_17
- Hamann M, Bensmann E, Andrulat A, et al. Real-world data of perioperative complications in prepectoral implant-based breast reconstruction: a prospective cohort study. Arch Gynecol Obstet. 2024;310(6):3077-3089. doi:10.1007/s00404-024-07807-5
- Phillips BT, Fourman MS, Bishawi M, et al. Are prophylactic postoperative antibiotics necessary for immediate breast reconstruction? Results of a prospective randomized clinical trial. J Am Coll Surg. 2016;222(6):1116-1124. doi:10.1016/j.jamcollsurg.2016.02.018
- Sergesketter AR, Langdell HC, Shammas RL, et al. Efficacy of prophylactic postoperative antibiotics in tissue expander-based breast reconstruction: a propensity score-matched analysis. Plast Reconstr Surg. 2024;153(3):496e-504e. doi:10.1097/PRS.0000000000010825
- In SK, Park SW, Myung Y. Effect of perioperative prophylactic intravenous antibiotic use in immediate implant-based breast reconstruction: a retrospective matched cohort study. Arch Plast Surg. 2024;51(1):36-41. doi:10.1055/a-2161-7521
- Baker NF, Hart AM, Carlson GW, Losken A. A systematic review of breast irrigation in implant-based breast surgery. Ann Plast Surg. 2021;86(3):359-364. doi:10.1097/SAP.0000000000002481
- Graziano FD, Shammas RL, Mehrara BJ, Rochlin DH. Local antibiotic delivery systems for infection prophylaxis in implant-based breast reconstruction: what is the evidence? Ann Plast Surg. 2025;95(5):499-505. doi:10.1097/SAP.0000000000004416
- Chicco M, Huang TC, Cheng HT. Negative-pressure wound therapy in the prevention and management of complications from prosthetic breast reconstruction: a systematic review and meta-analysis. Ann Plast Surg. 2021;87(4):478-483. doi:10.1097/SAP.0000000000002722
- Marcasciano M, Kaciulyte J, Di Giuli R, et al. “Just pulse it!” Introduction of a conservative implant salvage protocol to manage infection in pre-pectoral breast reconstruction: case series and literature review. J Plast Reconstr Aesthet Surg. 2022;75(2):571-578. doi:10.1016/j.bjps.2021.09.060
- O’Connor MJ, Huffman KN, Ho K, et al. Negative pressure wound therapy with instillation for periprosthetic infection after breast reconstruction: a systematic review. Plast Reconstr Surg Glob Open. 2024;12(11):e6267. doi:10.1097/GOX.0000000000006267
- De Pellegrin L, Zucal I, Treglia G, et al. Salvage of the mastectomy pocket in infected implant-based breast reconstruction using negative-pressure wound therapy with instillation and dwell: a systematic review and meta-analysis. J Clin Med. 2025;14(8):2730. doi:10.3390/jcm14082730
Important information This article is general education, not medical advice. Tap to read the full medical, regulatory & legal notice.
This article is provided by Advanced Biomedical Concept for general informational and educational purposes only. It does not constitute medical, surgical, diagnostic, or other professional healthcare advice, and it is not a substitute for consultation with a suitably qualified healthcare professional. Reading it creates no doctor–patient or other professional relationship. Nothing here should be used to diagnose, treat, cure, or prevent any disease or condition, or to make decisions about medical care. Always seek the advice of a physician or other qualified provider with any questions about a medical condition or treatment, and never disregard or delay professional advice because of something you have read here.
Any reference to Advanced Biomedical Concept products (including ExaShape and ExaFat) is provided for general information only. These are medical devices intended to be used by appropriately trained healthcare professionals strictly in accordance with their applicable, current Instructions for Use (IFU). Regulatory status (including CE marking and classification under the EU Medical Device Regulation), market availability, and approved indications differ between countries and may change over time; a device referred to here may not be available or approved in your country. This content is not intended as, and must not be relied upon as, a statement or claim of safety, clinical performance, or efficacy beyond what is set out in the applicable IFU and current regulatory approvals. Product-specific information is directed at healthcare professionals and is not intended to promote, advertise, or offer any medical device to the general public where such promotion is restricted or prohibited by law.
Statements reflect information believed to be accurate at the date of publication and may be updated or corrected without notice. Any statements regarding the future are expectations or general views, not guarantees. Clinical outcomes depend on many individual factors, results vary from person to person, and no particular result is promised or implied. Where third-party studies, sources, or external links are referenced, they are provided for convenience and information only and do not imply endorsement, and Advanced Biomedical Concept is not responsible for their content.
To the fullest extent permitted by applicable law, Advanced Biomedical Concept and its officers, employees, contributors, and representatives (each acting in that capacity and on behalf of Advanced Biomedical Concept) accept no liability for any loss, injury, or damage of any kind arising directly or indirectly from use of, or reliance on, this content. Nothing in this notice excludes or limits any liability that cannot lawfully be excluded or limited.
Questions about this material can be directed to us via our contact page.
Last reviewed: November 16, 2026.